Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5082502
Max Phase: Preclinical
Molecular Formula: C22H35NO20
Molecular Weight: 633.51
Molecule Type: Unknown
Associated Items:
ID: ALA5082502
Max Phase: Preclinical
Molecular Formula: C22H35NO20
Molecular Weight: 633.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@@H]3O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C22H35NO20/c23-1-2-37-3-4-38-20-10(29)7(26)12(15(42-20)18(33)34)40-22-11(30)8(27)13(16(43-22)19(35)36)39-21-9(28)5(24)6(25)14(41-21)17(31)32/h5-16,20-22,24-30H,1-4,23H2,(H,31,32)(H,33,34)(H,35,36)/t5-,6-,7+,8+,9+,10+,11+,12-,13-,14+,15+,16+,20+,21+,22+/m0/s1
Standard InChI Key: NMWXIQVXAJOCSZ-XLWQTZEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 633.51 | Molecular Weight (Monoisotopic): 633.1752 | AlogP: -7.30 | #Rotatable Bonds: 13 |
Polar Surface Area: 344.14 | Molecular Species: ZWITTERION | HBA: 18 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.62 | CX Basic pKa: 9.44 | CX LogP: -8.36 | CX LogD: -14.92 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.08 | Np Likeness Score: 0.92 |
1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800] |
Source(1):